The biotech industry?s surge in 2013 seems to have cooled in recent weeks as the sector has been hit by a broad …
Today’s stock suggestion is biopharmaceutical company Medivation (MDVN). Continue Reading Below Medivation works in collaboration with drug companies to develop novel therapies for serious diseases. They’re building their success in …